Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Teva API, Inc.
FDA Inspection
•Teva API, Inc.•July 18, 2017

Teva API, Inc. – FDA Inspection, Jul 18, 2017

Record Details

This FDA Inspection record concerns Teva API, Inc., with an inspection on July 18, 2017, issued by the New Jersey District Office, covering medical devices & rad health.

Company
Teva API, Inc.
Inspection Date
July 18, 2017
Product Type
Medical Devices & Rad Health
Office
New Jersey District Office
Person
  • Peter R. Lenahan (FDA Associated Person)
View Company Profile

ID · aff4b425-2846-468c-89f0-cee1af1d3529

Inspection Facts

Inspection number
1019140
FDA center
Medical Devices & Rad Health
Project area
Project Evaluation: Devices
Outcome
Form 483 issued

FDA Citations

1
  1. 21 CFR 812.40Sponsors' general responsibilities

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teva API, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.